Galera Therapeutics Inc (GRTX)

$0.13

Market is closed - opens 7 PM, 23 Jul 2024

Performance

  • $0.12
    $0.13
    $0.13
    downward going graph

    11.54%

    Downside

    Day's Volatility :11.54%

    Upside

    0.0%

    downward going graph
  • $0.09
    $3.59
    $0.13
    downward going graph

    34.38%

    Downside

    52 Weeks Volatility :97.62%

    Upside

    96.38%

    downward going graph

Returns

PeriodGalera Therapeutics IncIndex (Russel 2000)
3 Months
-33.51%
0.0%
6 Months
-28.25%
0.0%
1 Year
-95.0%
0.0%
3 Years
-98.61%
-19.9%

Highlights

Market Capitalization
7.0M
Book Value
- $2.48
Earnings Per Share (EPS)
-0.91
Wall Street Target Price
0.5
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-59.29%
Return On Equity TTM
-1063.11%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-37.4M
Diluted Eps TTM
-0.91
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Hold
    0
    0%Buy
    57%Hold
    42%Sell
Based on 7 Wall street analysts offering stock ratings for Galera Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
4
4
4
Sell
3
3
3

Analyst Forecast

What analysts predicted

Upside of 284.62%

Current $0.13
Target $0.50

Technicals Summary

Sell

Neutral

Buy

Galera Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Galera Therapeutics Inc
Galera Therapeutics Inc
9.93%
-28.25%
-95.0%
-98.61%
-98.93%
Moderna, Inc.
Moderna, Inc.
-10.58%
20.19%
-0.41%
-64.88%
800.74%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.55%
12.06%
47.12%
82.44%
245.9%
Novo Nordisk A/s
Novo Nordisk A/s
-6.4%
26.39%
64.35%
193.51%
440.83%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.41%
12.78%
38.89%
147.34%
182.99%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Galera Therapeutics Inc
Galera Therapeutics Inc
NA
NA
NA
0.0
-10.63
-0.59
NA
-2.48
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.45
31.45
1.46
44.4
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.05
45.05
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.94
31.94
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Galera Therapeutics Inc
Galera Therapeutics Inc
Hold
$12.5M
-98.93%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.4B
800.74%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.2B
245.9%
31.45
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$591.7B
440.83%
45.05
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.9B
182.99%
31.94
39.46%

Insights on Galera Therapeutics Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 60.8% return, outperforming this stock by 156.1%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 193.5% return, outperforming this stock by 292.1%

Institutional Holdings

  • GSA Capital Partners LLP

    6.68%
  • Sofinnova Ventures

    5.67%
  • Blackstone Inc

    3.09%
  • abrdn PLC

    1.65%
  • Vanguard Group Inc

    0.82%
  • Geode Capital Management, LLC

    0.81%

Company Information

galera therapeutics, inc. is a pharmaceuticals company located in 101 lindenwood dr, malvern, pennsylvania, united states.

Organization
Galera Therapeutics Inc
Employees
7
CEO
Dr. J. Mel Sorensen M.D.
Industry
Health Technology

FAQs